Global and China Short Bowel Syndrome Drugs Market Insights, Forecast to 2026

Publisher Name :
Date: 30-Nov-2020
No. of pages: 133
Inquire Before Buying

Short Bowel Syndrome Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Short Bowel Syndrome Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Short Bowel Syndrome Drugs market is segmented into

- Oral Route

- Parental Route

Segment by Application, the Short Bowel Syndrome Drugs market is segmented into

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

Regional and Country-level Analysis

The Short Bowel Syndrome Drugs market is analysed and market size information is provided by regions (countries).

The key regions covered in the Short Bowel Syndrome Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Short Bowel Syndrome Drugs Market Share Analysis

Short Bowel Syndrome Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Short Bowel Syndrome Drugs business, the date to enter into the Short Bowel Syndrome Drugs market, Short Bowel Syndrome Drugs product introduction, recent developments, etc.

The major vendors covered:

- Emmaus Medical

- Merck

- Takeda

- Ardelyx

- Naia Pharmaceuticals

- Nutrinia

- OxThera

- GLyPharma Therapeutic

- Sancilio Pharmaceuticals

- Zealand Pharma

Global and China Short Bowel Syndrome Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Short Bowel Syndrome Drugs Product Introduction
1.2 Market Segments
1.3 Key Short Bowel Syndrome Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Short Bowel Syndrome Drugs Market Size Growth Rate by Type
1.4.2 Oral Route
1.4.3 Parental Route
1.5 Market by Application
1.5.1 Global Short Bowel Syndrome Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Short Bowel Syndrome Drugs Market Size, Estimates and Forecasts
2.1.1 Global Short Bowel Syndrome Drugs Revenue 2015-2026
2.1.2 Global Short Bowel Syndrome Drugs Sales 2015-2026
2.2 Global Short Bowel Syndrome Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Short Bowel Syndrome Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Short Bowel Syndrome Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Short Bowel Syndrome Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Short Bowel Syndrome Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Short Bowel Syndrome Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Short Bowel Syndrome Drugs Revenue Forecast by Region (2021-2026)
3 Global Short Bowel Syndrome Drugs Competitor Landscape by Players
3.1 Global Top Short Bowel Syndrome Drugs Sales by Manufacturers
3.1.1 Global Short Bowel Syndrome Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Short Bowel Syndrome Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Short Bowel Syndrome Drugs Manufacturers by Revenue
3.2.1 Global Short Bowel Syndrome Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Short Bowel Syndrome Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Short Bowel Syndrome Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Short Bowel Syndrome Drugs Revenue in 2019
3.2.5 Global Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Short Bowel Syndrome Drugs Price by Manufacturers
3.4 Global Short Bowel Syndrome Drugs Manufacturing Base Distribution, Product Types
3.4.1 Short Bowel Syndrome Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Short Bowel Syndrome Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Short Bowel Syndrome Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Short Bowel Syndrome Drugs Market Size by Type (2015-2020)
4.1.1 Global Short Bowel Syndrome Drugs Sales by Type (2015-2020)
4.1.2 Global Short Bowel Syndrome Drugs Revenue by Type (2015-2020)
4.1.3 Short Bowel Syndrome Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Short Bowel Syndrome Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Short Bowel Syndrome Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Short Bowel Syndrome Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Short Bowel Syndrome Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Short Bowel Syndrome Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Short Bowel Syndrome Drugs Market Size by Application (2015-2020)
5.1.1 Global Short Bowel Syndrome Drugs Sales by Application (2015-2020)
5.1.2 Global Short Bowel Syndrome Drugs Revenue by Application (2015-2020)
5.1.3 Short Bowel Syndrome Drugs Price by Application (2015-2020)
5.2 Short Bowel Syndrome Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Short Bowel Syndrome Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Short Bowel Syndrome Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Short Bowel Syndrome Drugs Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Short Bowel Syndrome Drugs Market Size YoY Growth 2015-2026
6.1.1 China Short Bowel Syndrome Drugs Sales YoY Growth 2015-2026
6.1.2 China Short Bowel Syndrome Drugs Revenue YoY Growth 2015-2026
6.1.3 China Short Bowel Syndrome Drugs Market Share in Global Market 2015-2026
6.2 China Short Bowel Syndrome Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Short Bowel Syndrome Drugs Players by Sales (2015-2020)
6.2.2 China Top Short Bowel Syndrome Drugs Players by Revenue (2015-2020)
6.3 China Short Bowel Syndrome Drugs Historic Market Review by Type (2015-2020)
6.3.1 China Short Bowel Syndrome Drugs Sales Market Share by Type (2015-2020)
6.3.2 China Short Bowel Syndrome Drugs Revenue Market Share by Type (2015-2020)
6.3.3 China Short Bowel Syndrome Drugs Price by Type (2015-2020)
6.4 China Short Bowel Syndrome Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Short Bowel Syndrome Drugs Sales Forecast by Type (2021-2026)
6.4.2 China Short Bowel Syndrome Drugs Revenue Forecast by Type (2021-2026)
6.4.3 China Short Bowel Syndrome Drugs Price Forecast by Type (2021-2026)
6.5 China Short Bowel Syndrome Drugs Historic Market Review by Application (2015-2020)
6.5.1 China Short Bowel Syndrome Drugs Sales Market Share by Application (2015-2020)
6.5.2 China Short Bowel Syndrome Drugs Revenue Market Share by Application (2015-2020)
6.5.3 China Short Bowel Syndrome Drugs Price by Application (2015-2020)
6.6 China Short Bowel Syndrome Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Short Bowel Syndrome Drugs Sales Forecast by Application (2021-2026)
6.6.2 China Short Bowel Syndrome Drugs Revenue Forecast by Application (2021-2026)
6.6.3 China Short Bowel Syndrome Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Short Bowel Syndrome Drugs Market Size YoY Growth 2015-2026
7.2 North America Short Bowel Syndrome Drugs Market Facts & Figures by Country
7.2.1 North America Short Bowel Syndrome Drugs Sales by Country (2015-2020)
7.2.2 North America Short Bowel Syndrome Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Short Bowel Syndrome Drugs Market Size YoY Growth 2015-2026
8.2 Europe Short Bowel Syndrome Drugs Market Facts & Figures by Country
8.2.1 Europe Short Bowel Syndrome Drugs Sales by Country
8.2.2 Europe Short Bowel Syndrome Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Short Bowel Syndrome Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Short Bowel Syndrome Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Short Bowel Syndrome Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Short Bowel Syndrome Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Short Bowel Syndrome Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Short Bowel Syndrome Drugs Market Facts & Figures by Country
10.2.1 Latin America Short Bowel Syndrome Drugs Sales by Country
10.2.2 Latin America Short Bowel Syndrome Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Short Bowel Syndrome Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Short Bowel Syndrome Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Short Bowel Syndrome Drugs Sales by Country
11.2.2 Middle East and Africa Short Bowel Syndrome Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Emmaus Medical
12.1.1 Emmaus Medical Corporation Information
12.1.2 Emmaus Medical Description and Business Overview
12.1.3 Emmaus Medical Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Emmaus Medical Short Bowel Syndrome Drugs Products Offered
12.1.5 Emmaus Medical Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Description and Business Overview
12.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Short Bowel Syndrome Drugs Products Offered
12.2.5 Merck Recent Development
12.3 Takeda
12.3.1 Takeda Corporation Information
12.3.2 Takeda Description and Business Overview
12.3.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Takeda Short Bowel Syndrome Drugs Products Offered
12.3.5 Takeda Recent Development
12.4 Ardelyx
12.4.1 Ardelyx Corporation Information
12.4.2 Ardelyx Description and Business Overview
12.4.3 Ardelyx Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Ardelyx Short Bowel Syndrome Drugs Products Offered
12.4.5 Ardelyx Recent Development
12.5 Naia Pharmaceuticals
12.5.1 Naia Pharmaceuticals Corporation Information
12.5.2 Naia Pharmaceuticals Description and Business Overview
12.5.3 Naia Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Naia Pharmaceuticals Short Bowel Syndrome Drugs Products Offered
12.5.5 Naia Pharmaceuticals Recent Development
12.6 Nutrinia
12.6.1 Nutrinia Corporation Information
12.6.2 Nutrinia Description and Business Overview
12.6.3 Nutrinia Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Nutrinia Short Bowel Syndrome Drugs Products Offered
12.6.5 Nutrinia Recent Development
12.7 OxThera
12.7.1 OxThera Corporation Information
12.7.2 OxThera Description and Business Overview
12.7.3 OxThera Sales, Revenue and Gross Margin (2015-2020)
12.7.4 OxThera Short Bowel Syndrome Drugs Products Offered
12.7.5 OxThera Recent Development
12.8 GLyPharma Therapeutic
12.8.1 GLyPharma Therapeutic Corporation Information
12.8.2 GLyPharma Therapeutic Description and Business Overview
12.8.3 GLyPharma Therapeutic Sales, Revenue and Gross Margin (2015-2020)
12.8.4 GLyPharma Therapeutic Short Bowel Syndrome Drugs Products Offered
12.8.5 GLyPharma Therapeutic Recent Development
12.9 Sancilio Pharmaceuticals
12.9.1 Sancilio Pharmaceuticals Corporation Information
12.9.2 Sancilio Pharmaceuticals Description and Business Overview
12.9.3 Sancilio Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Products Offered
12.9.5 Sancilio Pharmaceuticals Recent Development
12.10 Zealand Pharma
12.10.1 Zealand Pharma Corporation Information
12.10.2 Zealand Pharma Description and Business Overview
12.10.3 Zealand Pharma Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Zealand Pharma Short Bowel Syndrome Drugs Products Offered
12.10.5 Zealand Pharma Recent Development
12.11 Emmaus Medical
12.11.1 Emmaus Medical Corporation Information
12.11.2 Emmaus Medical Description and Business Overview
12.11.3 Emmaus Medical Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Emmaus Medical Short Bowel Syndrome Drugs Products Offered
12.11.5 Emmaus Medical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Short Bowel Syndrome Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Short Bowel Syndrome Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Short Bowel Syndrome Drugs Market Segments
Table 2. Ranking of Global Top Short Bowel Syndrome Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Short Bowel Syndrome Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Oral Route
Table 5. Major Manufacturers of Parental Route
Table 6. Global Short Bowel Syndrome Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 7. Global Short Bowel Syndrome Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 8. Global Short Bowel Syndrome Drugs Sales by Regions 2015-2020 (K Pcs)
Table 9. Global Short Bowel Syndrome Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Short Bowel Syndrome Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Short Bowel Syndrome Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 12. Global Short Bowel Syndrome Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 13. Global Short Bowel Syndrome Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Short Bowel Syndrome Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Short Bowel Syndrome Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Short Bowel Syndrome Drugs as of 2019)
Table 16. Short Bowel Syndrome Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Short Bowel Syndrome Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Short Bowel Syndrome Drugs Price (2015-2020) (USD/Pcs)
Table 19. Short Bowel Syndrome Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Short Bowel Syndrome Drugs Product Type
Table 21. Date of International Manufacturers Enter into Short Bowel Syndrome Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Short Bowel Syndrome Drugs Sales by Type (2015-2020) (K Pcs)
Table 24. Global Short Bowel Syndrome Drugs Sales Share by Type (2015-2020)
Table 25. Global Short Bowel Syndrome Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Short Bowel Syndrome Drugs Revenue Share by Type (2015-2020)
Table 27. Short Bowel Syndrome Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 28. Global Short Bowel Syndrome Drugs Sales Share by Type (2021-2026)
Table 29. Global Short Bowel Syndrome Drugs Sales by Application (2015-2020) (K Pcs)
Table 30. Global Short Bowel Syndrome Drugs Sales Share by Application (2015-2020)
Table 31. Global Short Bowel Syndrome Drugs Sales Share by Application (2021-2026)
Table 32. Global Short Bowel Syndrome Drugs Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Short Bowel Syndrome Drugs Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Short Bowel Syndrome Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 35. China Short Bowel Syndrome Drugs Sales (K Pcs) of Key Companies (2015-2020)
Table 36. China Short Bowel Syndrome Drugs Sales Share by Company (2015-2020)
Table 37. China Short Bowel Syndrome Drugs Revenue (US$ Million) by Company (2015-2020)
Table 38. China Short Bowel Syndrome Drugs Sales (K Pcs) by Type (2015-2020)
Table 39. China Short Bowel Syndrome Drugs Sales Share by Type (2015-2020)
Table 40. China Short Bowel Syndrome Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. China Short Bowel Syndrome Drugs Price (K Pcs) by Type (2015-2020)
Table 42. China Short Bowel Syndrome Drugs Sales (K Pcs) by Type (2021-2026)
Table 43. China Short Bowel Syndrome Drugs Sales Share by Type (2021-2026)
Table 44. China Short Bowel Syndrome Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. China Short Bowel Syndrome Drugs Revenue Share by Type (2021-2026)
Table 46. China Short Bowel Syndrome Drugs Price (K Pcs) by Type (2021-2026)
Table 47. China Short Bowel Syndrome Drugs Sales (K Pcs) by Application (2015-2020)
Table 48. China Short Bowel Syndrome Drugs Sales Share by Application (2015-2020)
Table 49. China Short Bowel Syndrome Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. China Short Bowel Syndrome Drugs Sales (K Pcs) by Application (2021-2026)
Table 51. China Short Bowel Syndrome Drugs Sales Share by Application (2021-2026)
Table 52. China Short Bowel Syndrome Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. China Short Bowel Syndrome Drugs Revenue Share by Application (2021-2026)
Table 54. North America Short Bowel Syndrome Drugs Sales by Country (2015-2020) (K Pcs)
Table 55. North America Short Bowel Syndrome Drugs Sales Market Share by Country (2015-2020)
Table 56. North America Short Bowel Syndrome Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Short Bowel Syndrome Drugs Revenue Market Share by Country (2015-2020)
Table 58. Europe Short Bowel Syndrome Drugs Sales by Country (2015-2020) (K Pcs)
Table 59. Europe Short Bowel Syndrome Drugs Sales Market Share by Country (2015-2020)
Table 60. Europe Short Bowel Syndrome Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Short Bowel Syndrome Drugs Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Short Bowel Syndrome Drugs Sales by Region (2015-2020) (K Pcs)
Table 63. Asia Pacific Short Bowel Syndrome Drugs Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Short Bowel Syndrome Drugs Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Short Bowel Syndrome Drugs Revenue Market Share by Region (2015-2020)
Table 66. Latin America Short Bowel Syndrome Drugs Sales by Country (2015-2020) (K Pcs)
Table 67. Latin America Short Bowel Syndrome Drugs Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Short Bowel Syndrome Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Short Bowel Syndrome Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Short Bowel Syndrome Drugs Sales by Country (2015-2020) (K Pcs)
Table 71. Middle East and Africa Short Bowel Syndrome Drugs Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Short Bowel Syndrome Drugs Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Short Bowel Syndrome Drugs Revenue Market Share by Country (2015-2020)
Table 74. Emmaus Medical Corporation Information
Table 75. Emmaus Medical Description and Business Overview
Table 76. Emmaus Medical Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. Emmaus Medical Short Bowel Syndrome Drugs Product
Table 78. Emmaus Medical Recent Development
Table 79. Merck Corporation Information
Table 80. Merck Description and Business Overview
Table 81. Merck Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. Merck Product
Table 83. Merck Recent Development
Table 84. Takeda Corporation Information
Table 85. Takeda Description and Business Overview
Table 86. Takeda Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Takeda Product
Table 88. Takeda Recent Development
Table 89. Ardelyx Corporation Information
Table 90. Ardelyx Description and Business Overview
Table 91. Ardelyx Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Ardelyx Product
Table 93. Ardelyx Recent Development
Table 94. Naia Pharmaceuticals Corporation Information
Table 95. Naia Pharmaceuticals Description and Business Overview
Table 96. Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. Naia Pharmaceuticals Product
Table 98. Naia Pharmaceuticals Recent Development
Table 99. Nutrinia Corporation Information
Table 100. Nutrinia Description and Business Overview
Table 101. Nutrinia Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Nutrinia Product
Table 103. Nutrinia Recent Development
Table 104. OxThera Corporation Information
Table 105. OxThera Description and Business Overview
Table 106. OxThera Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. OxThera Product
Table 108. OxThera Recent Development
Table 109. GLyPharma Therapeutic Corporation Information
Table 110. GLyPharma Therapeutic Description and Business Overview
Table 111. GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. GLyPharma Therapeutic Product
Table 113. GLyPharma Therapeutic Recent Development
Table 114. Sancilio Pharmaceuticals Corporation Information
Table 115. Sancilio Pharmaceuticals Description and Business Overview
Table 116. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Sancilio Pharmaceuticals Product
Table 118. Sancilio Pharmaceuticals Recent Development
Table 119. Zealand Pharma Corporation Information
Table 120. Zealand Pharma Description and Business Overview
Table 121. Zealand Pharma Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. Zealand Pharma Product
Table 123. Zealand Pharma Recent Development
Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 125. Key Challenges
Table 126. Market Risks
Table 127. Main Points Interviewed from Key Short Bowel Syndrome Drugs Players
Table 128. Short Bowel Syndrome Drugs Customers List
Table 129. Short Bowel Syndrome Drugs Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Short Bowel Syndrome Drugs Product Picture
Figure 2. Global Short Bowel Syndrome Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Route Product Picture
Figure 4. Parental Route Product Picture
Figure 5. Global Short Bowel Syndrome Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Short Bowel Syndrome Drugs Report Years Considered
Figure 10. Global Short Bowel Syndrome Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Short Bowel Syndrome Drugs Sales 2015-2026 (K Pcs)
Figure 12. Global Short Bowel Syndrome Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Short Bowel Syndrome Drugs Sales Market Share by Region in 2019
Figure 15. Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Short Bowel Syndrome Drugs Revenue Market Share by Region in 2019
Figure 17. Global Short Bowel Syndrome Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Short Bowel Syndrome Drugs Revenue in 2019
Figure 19. Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Short Bowel Syndrome Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Short Bowel Syndrome Drugs Sales Market Share by Type in 2019
Figure 22. Global Short Bowel Syndrome Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Short Bowel Syndrome Drugs Revenue Market Share by Type in 2019
Figure 24. Global Short Bowel Syndrome Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Short Bowel Syndrome Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Short Bowel Syndrome Drugs Sales Market Share by Application in 2019
Figure 27. Global Short Bowel Syndrome Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Short Bowel Syndrome Drugs Revenue Market Share by Application in 2019
Figure 29. China Short Bowel Syndrome Drugs Sales Growth Rate 2015-2026 (K Pcs)
Figure 30. China Short Bowel Syndrome Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 31. China Short Bowel Syndrome Drugs Market Share in Global Market 2015-2026
Figure 32. China 5 and 10 Largest Short Bowel Syndrome Drugs Players Market Share by Revenue in Short Bowel Syndrome Drugs in 2019
Figure 33. China Short Bowel Syndrome Drugs Revenue Share by Type (2015-2020)
Figure 34. China Short Bowel Syndrome Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 35. China Short Bowel Syndrome Drugs Revenue Share by Application (2015-2020)
Figure 36. China Short Bowel Syndrome Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 37. North America Short Bowel Syndrome Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 38. North America Short Bowel Syndrome Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 39. North America Short Bowel Syndrome Drugs Sales Market Share by Country in 2019
Figure 40. North America Short Bowel Syndrome Drugs Revenue Market Share by Country in 2019
Figure 41. U.S. Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 42. U.S. Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Canada Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 44. Canada Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Europe Short Bowel Syndrome Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 46. Europe Short Bowel Syndrome Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Short Bowel Syndrome Drugs Sales Market Share by Country in 2019
Figure 48. Europe Short Bowel Syndrome Drugs Revenue Market Share by Country in 2019
Figure 49. Germany Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Germany Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. France Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. U.K. Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Italy Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Asia Pacific Short Bowel Syndrome Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Short Bowel Syndrome Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Short Bowel Syndrome Drugs Sales Market Share by Region in 2019
Figure 62. Asia Pacific Short Bowel Syndrome Drugs Revenue Market Share by Region in 2019
Figure 63. China Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Latin America Short Bowel Syndrome Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Short Bowel Syndrome Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Short Bowel Syndrome Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Short Bowel Syndrome Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Middle East and Africa Short Bowel Syndrome Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 96. Middle East and Africa Short Bowel Syndrome Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Short Bowel Syndrome Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Short Bowel Syndrome Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 100. Turkey Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Saudi Arabia Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Short Bowel Syndrome Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. U.A.E Short Bowel Syndrome Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Porter's Five Forces Analysis
Figure 106. Short Bowel Syndrome Drugs Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed
  • Global Recombinant Human Erythropoietin (rhEPO) Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - ESRD - Cancer - HIV - Wounds and Neural Disease Segment by Application - Hospi......
  • Global rhEPO Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 97
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - ESRD - Cancer - HIV - Wounds and neural disease Segment by Application - Hospi......
  • Global Rhematoid Arthritis Drugs Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 94
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Pharmaceuticals - Biopharmaceuticals Segment by Application - Prescription - OTC......
  • Global Chronic Obstructive Pulmonary Disease Drugs Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 118
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Inhalers - Nebulizers Segment by Application - Emphysema - Chronic Bronchitis ......
  • Global Chronic Lymphocytic Leukemia Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 121
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Acutemyeloid (ormyelogenous)leukemia (AML) - Chronicmyeloid (ormyelogenous)leukemia (CML) - Acutelymphocyti......
  • Global Chemotherapy-induced Nausea and Vomiting Drugs Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 93
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - 5-HT3 Inhibitors - NK1 Inhibitors - Other Segment by Application - Highly Emetogenic ......
  • Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 120
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Aloxi (Palonosetron) - Kytril Generic (Granisetron) - Emend (Aprepitant) - Akynzeo (Netupitant-Palon......
  • Global ß-blockers Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 122
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Nonselective Agents - Selective Agents Segment by Application - Abnormal Heart Rhythms......
  • Global a-adrenoreceptor Antagonists Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 116
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Non-selective Antagonists - Selective Antagonists Segment by Application - Hypertension......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs